Bulltick Wealth Management LLC Increases Holdings in UnitedHealth Group Incorporated $UNH

Bulltick Wealth Management LLC increased its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 200.8% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 23,945 shares of the healthcare conglomerate’s stock after purchasing an additional 15,985 shares during the period. UnitedHealth Group accounts for about 1.8% of Bulltick Wealth Management LLC’s holdings, making the stock its 12th biggest holding. Bulltick Wealth Management LLC’s holdings in UnitedHealth Group were worth $7,470,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in UNH. LFA Lugano Financial Advisors SA purchased a new stake in UnitedHealth Group in the 2nd quarter valued at about $25,000. Bayforest Capital Ltd raised its stake in shares of UnitedHealth Group by 685.7% in the 1st quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate’s stock valued at $29,000 after acquiring an additional 48 shares during the period. Islay Capital Management LLC purchased a new position in shares of UnitedHealth Group during the 2nd quarter worth approximately $31,000. Clal Insurance Enterprises Holdings Ltd raised its position in UnitedHealth Group by 416.7% in the first quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate’s stock valued at $32,000 after purchasing an additional 50 shares during the period. Finally, Glass Jacobson Investment Advisors llc grew its stake in shares of UnitedHealth Group by 80.9% in the second quarter. Glass Jacobson Investment Advisors llc now owns 123 shares of the healthcare conglomerate’s stock valued at $38,000 after buying an additional 55 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Wall Street Analysts Forecast Growth

UNH has been the topic of several research reports. Zacks Research raised shares of UnitedHealth Group from a “strong sell” rating to a “hold” rating in a research report on Monday, October 6th. JPMorgan Chase & Co. increased their target price on shares of UnitedHealth Group from $310.00 to $425.00 and gave the stock an “overweight” rating in a report on Thursday, October 9th. TD Cowen upped their price objective on UnitedHealth Group from $335.00 to $338.00 and gave the stock a “hold” rating in a research report on Thursday, October 30th. Piper Sandler lowered their target price on UnitedHealth Group from $423.00 to $417.00 and set an “overweight” rating for the company in a research note on Tuesday, October 28th. Finally, Morgan Stanley lifted their price objective on UnitedHealth Group from $325.00 to $395.00 and gave the company an “overweight” rating in a research note on Friday, September 12th. Eighteen equities research analysts have rated the stock with a Buy rating, nine have given a Hold rating and three have issued a Sell rating to the company’s stock. According to data from MarketBeat.com, UnitedHealth Group presently has an average rating of “Moderate Buy” and an average target price of $397.12.

UnitedHealth Group Trading Down 3.3%

NYSE UNH opened at $321.44 on Monday. UnitedHealth Group Incorporated has a 12 month low of $234.60 and a 12 month high of $622.83. The company has a market capitalization of $291.17 billion, a price-to-earnings ratio of 16.78, a price-to-earnings-growth ratio of 2.28 and a beta of 0.47. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.82 and a quick ratio of 0.85. The firm’s fifty day moving average price is $347.65 and its 200 day moving average price is $318.79.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.87 by $0.05. The company had revenue of $113.16 billion for the quarter, compared to analyst estimates of $113.19 billion. UnitedHealth Group had a return on equity of 19.23% and a net margin of 4.04%.The business’s quarterly revenue was up 12.2% compared to the same quarter last year. During the same quarter last year, the company posted $7.15 earnings per share. On average, sell-side analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 16th. Investors of record on Monday, December 8th will be given a $2.21 dividend. The ex-dividend date is Monday, December 8th. This represents a $8.84 annualized dividend and a yield of 2.8%. UnitedHealth Group’s dividend payout ratio is 46.14%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.